Hemas Holdings announces board-level leadership changes

Husein Esufally

Ajith Fernando

Murtaza Esufally

Dr. Anura Ekanayake

Hemas Holdings PLC yesterday announced upcoming changes to its director board, reflecting the Group’s commitment to strong governance and a seamless leadership transition.
Husein Esufally, who has served Hemas for over four decades in various leadership capacities including Group Chief Executive Officer and Chairman, will retire from the Board with effect from 31st December 2025. Under his stewardship, 
Hemas evolved into one of Sri Lanka’s most diversified conglomerates, delivering consistent value to stakeholders. The Board of Directors and the Hemas Group expressed its profound appreciation for his vision and dedication, which have been instrumental in shaping the Group’s purpose-driven culture and long-term success.
The Group also announced that Dr. Anura Ekanayake, Deputy Chairman, will retire on 31st December 2025 upon completion of his term. Dr. Ekanayake’s contributions to the Board and the Group have been significant, particularly in strengthening governance and providing strategic counsel during periods of transformation.
Effective 1 January 2026, Ajith Fernando will assume the role of Chairman of Hemas Holdings PLC. Fernando is widely recognised for his strategic insight and disciplined execution. His proven track record in building and scaling businesses positions him to guide Hemas through its next phase of growth and innovation.
To ensure continuity and reinforce Board oversight, Murtaza Esufally, current Chairman of the Healthcare cluster, has been appointed Deputy Chairman of Hemas Holdings PLC, effective January 2026. His deep industry expertise and longstanding leadership within the Group will support Hemas’ strategic priorities and governance framework.